홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

에베르코나졸

Eberconazole

HCID 72051
새 반응
인쇄
기본 정보개요이름 및 식별자물성화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
128326-82-9
표준 SMILES
Clc1cc(Cl)c2c(c1)CCc1ccccc1C2n1ccnc1
InChIKey
MPTJIDOGFUQSQH-UHFFFAOYSA-N
분자식
C18H14Cl2N2
평균 분자량
329.2 g/mol
단동위원소 질량
328.0534038

개요

1-(2,4-dichloro-10,11-dihydrodibenzo[a,d][7]annulen-5-yl)imidazole is a member of the class of dibenzannulenes that is 10,11-dihydrodibenzo[a,d][7]annulene carrying two chloro substituents at positions 2 and 4 as well as an imidazol-1-yl substituent at position 5. It is a member of imidazoles, a dibenzannulene and an organochlorine compound. It derives from a hydride of a dibenzo[a,d][7]annulene.

이름 및 식별자

우선 이름
Eberconazole
IUPAC
1-(4,6-dichloro-2-tricyclo[9.4.0.03,8]pentadeca-1(15),3(8),4,6,11,13-hexaenyl)imidazole
현지명
에베르코나졸
영어명
Eberconazole
분자식
C18H14Cl2N2
분자량
329.22

이름 및 동의어

Eberconazole128326-82-9EberconazolEberconazolumV7O1U41C9BDTXSID909261041-(2,4-dichloro-10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-yl)-1H-imidazoleRefChem:920795CHEBI:82862D01AC17DTXCID6013549231-(4,6-dichlorotricyclo(9.4.0.0^(3,8))pentadeca-1(15),3,5,7,11,13-hexaen-2-yl)-1H-imidazole
이름 더 보기
에베르코나졸1H-Imidazole, 1-(2,4-dichloro-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-(+/-)-1-(2,4-Dichloro-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)imidazole
Eberconazole [INN]1-(4,6-dichloro-2-tricyclo[9.4.0.03,8]pentadeca-1(15),3(8),4,6,11,13-hexaenyl)imidazole1-(2,4-dichloro-10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-yl)-1H-imidazoleEberconazole (INN)Eberconazol [INN-Spanish]Eberconazolum [INN-Latin]UNII-V7O1U41C9BWAS-2160

데이터베이스 식별자

CAS
128326-82-9

물성

구조 계산 물성

XLogP
4.9
극성 표면적
17.8 Ų
수소 결합 공여자 수
0
수소 결합 수용자 수
1
회전 가능 결합 수
1
무거운 원자 수
22
형식 전하
0
복잡도
391

물리화학적 성질

끓는 점
495 · 495.0±45.0 °C(Predicted)
밀도
1.35 · 1.35±0.1 g/cm3(Predicted)
산도 계수 (pKa)
5.84 · 5.84±0.10(Predicted)

화학 및 산업

약리 정보

ATC Code · 2건

D - Dermatologicals

QD - Dermatologicals

PharmacodynamicsEberconazole is active against Gram-positive bacteria, dermatophytes, and yeasts.
Mechanism of ActionEberconazole shares a mechanism of action with other antimycotic azoles: It inhibits lanosterol 14a-demethylase, thereby blocking the synthesis of precursors of ergosterols.
응용 분야 · 2건

개요Eberconazole is a new member of the azole class of antifungal agents, and it is indicated for the topical treatment of cutaneous fungal infections, including tinea corporis (ringworm of the body), tinea cruris (ringworm of the groin) and tinea pedis (athlete’s foot) infections. Its mode of action is similar to that of other azole antifungals, namely inhibition of fungal lanosterol 14α-demethylase. Eberconazole exhibits good in vitro activity against a wide range of Candida species, including Candida. tropicalis, dermatophytes and Malassezia spp. yeasts. It shows good activity against Candida. Parapsilosis (MIC90=0.125 mg/mL), which is a relevant species in skin and nail disorders. In addition, eberconazole is effective against some of the highly triazole-resistant yeasts such as Candida. glabrata and Candida. krusei, as well as fluconazole-resistant Candida. albicans. However, eberconazole is less active than clotrimazole and ketoconazole against Candida. neoformans and a number of clinically relevant molds. Eberconazole is supplied as a 1% or 2% cream, and the topical application does not result in detectable serum, urine, or fecal levels. In a phase II study of 60 patients with tinea corporis and tinea cruris, treatment with topical eberconazole (1% or 2% cream), applied once or twice daily for 6 weeks, resulted in cure rates ranging from 73.3–93.3% at the end of therapy, and 66.7–100% six weeks post-therapy.

용도Eberconazole can be used for a novel antifungal formulation.

관련 반응

0건
반응 기록 만들기
아직 관련 반응이 없습니다

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성화학 및 산업관련 반응화합물 노트
PubChem CID
72051
DTXSID
DTXSID90926104
ChEMBL
CHEMBL558722
ChEBI
CHEBI:83584
UNII
V7O1U41C9B
Nikkaji
J561.862B